From January 1, 2024 to March 31, 2024, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 1,814,653 shares, representing 3.1% for $49.99 million under the buyback announced on October 31, 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.84 USD | -0.47% | +0.31% | -8.64% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.64% | 1.7B | |
+42.81% | 748B | |
+34.01% | 598B | |
-5.79% | 356B | |
+18.00% | 325B | |
+4.54% | 283B | |
+17.04% | 245B | |
+9.07% | 211B | |
-4.13% | 209B | |
+2.24% | 166B |
- Stock Market
- Equities
- HRMY Stock
- News Harmony Biosciences Holdings, Inc.
- Tranche Update on Harmony Biosciences Holdings, Inc.'s Equity Buyback Plan announced on October 31, 2023.